Creative Planning - ACELRX PHARMACEUTICALS INC ownership

ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 48 filers reported holding ACELRX PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 0.93 and the average weighting 0.0%.

Quarter-by-quarter ownership
Creative Planning ownership history of ACELRX PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$3,000
-97.2%
15,500
-63.7%
0.00%
Q2 2019$108,000
-27.5%
42,722
-0.2%
0.00%
-100.0%
Q1 2019$149,000
+47.5%
42,802
-2.3%
0.00%
Q4 2018$101,000
-42.0%
43,802
-3.1%
0.00%
-100.0%
Q3 2018$174,000
+304.7%
45,222
+256.1%
0.00%
Q2 2018$43,000
+48.3%
12,700
-7.3%
0.00%
Q1 2018$29,000
+3.6%
13,7000.0%0.00%
Q4 2017$28,000
-58.8%
13,700
-6.8%
0.00%
Q3 2017$68,000
+78.9%
14,700
-16.9%
0.00%
Q2 2017$38,000
-13.6%
17,700
+25.5%
0.00%
Q1 2017$44,000
+15.8%
14,100
-3.4%
0.00%
Q4 2016$38,000
-30.9%
14,600
+3.5%
0.00%
Q3 2016$55,000
+44.7%
14,1000.0%0.00%
Q2 2016$38,000
-72.1%
14,100
-68.0%
0.00%
-100.0%
Q1 2016$136,000
+1.5%
44,100
+27.1%
0.00%0.0%
Q4 2015$134,000
-0.7%
34,700
-21.5%
0.00%0.0%
Q3 2015$135,000
-29.7%
44,200
-2.2%
0.00%
-50.0%
Q2 2015$192,000
+1100.0%
45,200
+976.2%
0.00%
Q1 2015$16,000
-36.0%
4,200
+15.1%
0.00%
Q4 2014$25,000
+316.7%
3,650
+217.4%
0.00%
Q3 2014$6,0001,1500.00%
Other shareholders
ACELRX PHARMACEUTICALS INC shareholders Q1 2018
NameSharesValueWeighting ↓
LINCOLN CAPITAL CORP 34,250$116,0000.11%
Kovack Advisors, Inc. 24,393$82,0000.02%
Cedar Wealth Management, LLC 12,000$41,0000.02%
Ausdal Financial Partners, Inc. 19,590$66,0000.02%
HRT FINANCIAL LP 15,990$53,0000.02%
Granite Investment Partners, LLC 53,853$182,0000.01%
Joel Isaacson & Co., LLC 20,000$68,0000.01%
GSA CAPITAL PARTNERS LLP 53,658$181,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 246,150$831,0000.01%
Dynamic Technology Lab Private Ltd 15,108$51,0000.01%
View complete list of ACELRX PHARMACEUTICALS INC shareholders